Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
BsUFA III Expands Biosimilar Supplement Review Goals To Speed Approvals
Sep 22 2021
•
By
Derrick Gingery
The FDA plans to hire an additional 15 employees to help implement the BsUFA III program changes.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from Pathways & Standards